Literature DB >> 24613241

Inhibition of vesicular glutamate transporters contributes to attenuate methamphetamine-induced conditioned place preference in rats.

Zongsheng He1, Yuan Chen1, Huajin Dong1, Ruibin Su1, Zehui Gong1, Lingdi Yan2.   

Abstract

Accumulating evidence suggests that glutamatergic system plays a crucial role in methamphetamine (METH) addiction. In the glutamatergic transmission, vesicular glutamate transporters (VGLUTs) are responsible for transporting glutamate into synaptic vesicles and affect the glutamate concentrations in the synaptic cleft. It is well documented that VGLUTs play an essential role in pathophysiology of several psychiatric and neurological diseases, however, whether VGLUTs also have a role in addiction caused by psychostimulant drugs is still unknown. The present study was underwent to investigate the effect of inhibition of VGLUTs on METH-induced induce conditioned place preference in rats. Rats were induced to conditioned place preference with METH (0.5, 1.0 and 2.0mg/kg) by intraperitoneal injection. Intracerebroventricular administration of 1.0 or 5.0μg Chicago sky blue 6B (CSB6B), a VGLUTs inhibitor, and 2.5h prior to METH was to observe its effect on METH-induced conditioned place preference in rats. The rats receiving METH showed stronger place preference at the dose of 1.0mg/kg than that of other doses. The intracerebroventricular administration of CSB6B (1.0, 5.0μg) 2.5h prior to the exposure to METH attenuated the acquisition of METH-induced conditioned place preference, while CSB6B itself had no effect on place preference. These results indicate that VGLUTs are involved in the effect of METH-induced conditioned place preference and may be a new target against METH addiction.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chicago sky blue 6B.; Conditioned place preference; Methamphetamine; Vesicular glutamate transporters

Mesh:

Substances:

Year:  2014        PMID: 24613241     DOI: 10.1016/j.bbr.2014.02.047

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

1.  Ceftriaxone attenuates acquisition and facilitates extinction of cocaine-induced suppression of saccharin intake in C57BL/6J mice.

Authors:  Christopher S Freet; Antoneal L Lawrence
Journal:  Physiol Behav       Date:  2015-06-09

2.  Monosodium glutamate-associated alterations in open field, anxiety-related and conditioned place preference behaviours in mice.

Authors:  Olakunle James Onaolapo; Olaleye Samuel Aremu; Adejoke Yetunde Onaolapo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-03-29       Impact factor: 3.000

3.  The Potential Role of PKA/CREB Signaling Pathway Concerned with Gastrodin Administration on Methamphetamine-Induced Conditioned Place Preference Rats and SH-SY5Y Cell Line.

Authors:  Gen-Meng Yang; Lu Li; Feng-Lin Xue; Chen-Li Ma; Xiao-Feng Zeng; Yong-Na Zhao; Dong-Xian Zhang; Yang Yu; Qian-Wen Yan; Yi-Qing Zhou; Shi-Jun Hong; Li-Hua Li
Journal:  Neurotox Res       Date:  2020-01-04       Impact factor: 3.911

4.  Pregabalin: Potential for Addiction and a Possible Glutamatergic Mechanism.

Authors:  Yusuf S Althobaiti; Atiah Almalki; Hashem Alsaab; Walaa Alsanie; Ahmed Gaber; Qasim Alhadidi; Ana Maria Gregio Hardy; Abdulrahman Nasr; Omar Alzahrani; Creed M Stary; Zahoor A Shah
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

Review 5.  The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.

Authors:  Sonia Mediouni; Maria Cecilia Garibaldi Marcondes; Courtney Miller; Jay P McLaughlin; Susana T Valente
Journal:  Front Microbiol       Date:  2015-10-23       Impact factor: 5.640

6.  Potential Benefits of N-Acetylcysteine in Preventing Pregabalin-Induced Seeking-Like Behavior.

Authors:  Atiah H Almalki; Hashem O Alsaab; Walaa F Alsanie; Ahmed Gaber; Turki Alkhalifa; Ahmad Almalki; Omar Alzahrani; Ana Maria Gregio Hardy; Qasim Alhadidi; Zahoor A Shah; Yusuf S Althobaiti
Journal:  Healthcare (Basel)       Date:  2021-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.